[{"address1": "11 Great Valley Parkway", "city": "Malvern", "state": "PA", "zip": "19355", "country": "United States", "phone": "484 328 4701", "website": "https://www.ocugen.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Ocugen, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel gene and cell therapies, biologic, and vaccines that improve patients' health. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, currently under Phase 3 trials for the treatment of retinitis pigmentosa and Phase 1/2 trials for the treatment of leber congenital amaurosis; OCU410, a gene therapy under phase 1/2 for the treatment of dry age-related macular degeneration (AMD); and OCU410ST, a gene therapy under phase 1/2 for the treatment of Stargardt disease. It is involved in the development of OCU200, a novel fusion protein for the treatment of diabetic macular edema, diabetic retinopathy, and wet age-related macular degeneration; and NeoCart, an autologous chondrocyte-derived neocartilage, currently under Phase 3 studies indicated for the repair of knee cartilage injuries in adult. In addition, the company is developing OCU500, a COVID-19 vaccine; OCU510, a seasonal quadrivalent flu vaccine; and OCU520, a combination quadrivalent seasonal flu and COVID-19 vaccine. It has collaboration agreements with National Institute of Allergy and Infectious Diseases for early clinical studies for the OCU500 program; and a strategic partnership with CanSino Biologics Inc. for manufacturing its modifier gene therapy pipeline product candidates. The company was founded in 2013 and is headquartered in Malvern, Pennsylvania.", "fullTimeEmployees": 95, "companyOfficers": [{"maxAge": 1, "name": "Dr. Shankar  Musunuri M.B.A., Ph.D.", "age": 60, "title": "Co-Founder, CEO & Chairman", "yearBorn": 1964, "fiscalYear": 2023, "totalPay": 864246, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Uday B. Kompella Ph.D.", "age": 57, "title": "Co-founder & Independent Director", "yearBorn": 1967, "fiscalYear": 2023, "totalPay": 60000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Arun  Upadhyay Ph.D.", "age": 41, "title": "Chief Scientific Officer and Head of Research & Development", "yearBorn": 1983, "fiscalYear": 2023, "totalPay": 598056, "exercisedValue": 0, "unexercisedValue": 4000}, {"maxAge": 1, "name": "Mr. Ramesh  Ramachandran C.M.A., CPA, M.B.A.", "title": "Principal Financial Officer & Principal Accounting Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "John  Kouch J.D.", "title": "General Counsel", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Tiffany J. Hamilton M.B.A.", "title": "AVP & Head of Corporate Communications", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kristen  Craft", "title": "Head of People & Culture", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michael  Shine M.B.A.", "title": "Senior Vice President of Commercial", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jyothy  Pillai M.S.", "title": "VP & Head of Regulatory & Quality", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Huma  Qamar CMI, M.D., M.P.H.", "age": 40, "title": "Chief Medical Officer", "yearBorn": 1984, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 10, "boardRisk": 7, "compensationRisk": 9, "shareHolderRightsRisk": 9, "overallRisk": 10, "governanceEpochDate": 1740787200, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.5163, "open": 0.515, "dayLow": 0.515, "dayHigh": 0.5402, "regularMarketPreviousClose": 0.5163, "regularMarketOpen": 0.515, "regularMarketDayLow": 0.515, "regularMarketDayHigh": 0.5402, "payoutRatio": 0.0, "beta": 3.893, "forwardPE": -2.0769231, "volume": 2164575, "regularMarketVolume": 2164575, "averageVolume": 4519451, "averageVolume10days": 4008300, "averageDailyVolume10Day": 4008300, "bid": 0.5102, "ask": 0.6071, "bidSize": 2, "askSize": 1, "marketCap": 157687568, "fiftyTwoWeekLow": 0.515, "fiftyTwoWeekHigh": 2.105, "priceToSalesTrailing12Months": 38.88719, "fiftyDayAverage": 0.69092, "twoHundredDayAverage": 1.066905, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 124756072, "profitMargins": 0.0, "floatShares": 287374360, "sharesOutstanding": 292014016, "sharesShort": 63673877, "sharesShortPriorMonth": 58883625, "sharesShortPreviousMonthDate": 1738281600, "dateShortInterest": 1740700800, "sharesPercentSharesOut": 0.2181, "heldPercentInsiders": 0.01271, "heldPercentInstitutions": 0.24841, "shortRatio": 18.84, "shortPercentOfFloat": 0.2217, "impliedSharesOutstanding": 292014016, "bookValue": 0.102, "priceToBook": 5.294118, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -54054000, "trailingEps": -0.2, "forwardEps": -0.26, "lastSplitFactor": "1:60", "lastSplitDate": 1569801600, "enterpriseToRevenue": 30.766, "enterpriseToEbitda": -2.363, "52WeekChange": -0.583871, "SandP52WeekChange": 0.07465422, "quoteType": "EQUITY", "currentPrice": 0.54, "targetHighPrice": 8.0, "targetLowPrice": 4.0, "targetMeanPrice": 6.75, "targetMedianPrice": 7.5, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 4, "totalCash": 58514000, "totalCashPerShare": 0.2, "ebitda": -52789000, "totalDebt": 32503000, "quickRatio": 2.71, "currentRatio": 2.857, "totalRevenue": 4055000, "debtToEquity": 109.689, "revenuePerShare": 0.015, "returnOnAssets": -0.46566, "returnOnEquity": -1.5400901, "grossProfits": -28071000, "freeCashflow": -24644124, "operatingCashflow": -42142000, "revenueGrowth": -0.458, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -18.11518, "financialCurrency": "USD", "symbol": "OCGN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "exchange": "NCM", "messageBoardId": "finmb_303874231", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 4.590354, "regularMarketPrice": 0.54, "marketState": "REGULAR", "corporateActions": [], "regularMarketTime": 1742412255, "epsTrailingTwelveMonths": -0.2, "epsForward": -0.26, "shortName": "Ocugen, Inc.", "longName": "Ocugen, Inc.", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1417617000000, "regularMarketChange": 0.023699999, "regularMarketDayRange": "0.515 - 0.5402", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 4519451, "fiftyTwoWeekLowChange": 0.025000036, "fiftyTwoWeekLowChangePercent": 0.04854376, "fiftyTwoWeekRange": "0.515 - 2.105", "fiftyTwoWeekHighChange": -1.565, "fiftyTwoWeekHighChangePercent": -0.7434679, "fiftyTwoWeekChangePercent": -58.3871, "dividendDate": 1569801600, "earningsTimestamp": 1741176120, "earningsTimestampStart": 1747053000, "earningsTimestampEnd": 1747398600, "earningsCallTimestampStart": 1741181400, "earningsCallTimestampEnd": 1741181400, "isEarningsDateEstimate": true, "epsCurrentYear": -0.26, "priceEpsCurrentYear": -2.0769231, "fiftyDayAverageChange": -0.15091997, "fiftyDayAverageChangePercent": -0.21843335, "twoHundredDayAverageChange": -0.526905, "twoHundredDayAverageChangePercent": -0.49386308, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.5 - Strong Buy", "displayName": "Ocugen", "trailingPegRatio": null, "__fetch_time": "2025-03-19"}]